Atlas Trials

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

Clinical trial NCT07386340 · RECRUITING

Trial details

NCT number
NCT07386340
Sponsor
Senseonics, Inc.
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2025-12-29
Primary completion
2027-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.